Pfizer 1Q 1Q Revenues: $16.5 billion (flat) 1Q Earnings: $2.2 billion (+10%) Comments: Revenue figures for 1Q11 include two months of King Pharma revenues (Feb. 1 to March 31, 2011), totaling $224 million. Primary care revenues dropped 7% to $5.4 billion, Speciality Care was up 12% to $3.9 billion, Established Products fell 15% to $2.4 billion, Emerging Markets grew 10% to $2.2 billion, and Oncology was down 14% to $311 million. Primary Care was affected by loss of Lipitor patent protec...